Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.08
+1.34 (15.33%)
At close: Dec 20, 2024, 4:00 PM
10.06
-0.02 (-0.20%)
After-hours: Dec 20, 2024, 7:14 PM EST
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $535.07 million as of December 20, 2024. Its market cap has decreased by -79.61% in one year.
Market Cap
535.07M
Enterprise Value
364.44M
1-Year Change
-79.61%
Ranking
Category
Stock Price
$10.08
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $535.07M, a decrease of -75.48%. That is a compound annual growth rate of -31.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 535.07M | -83.95% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 481.97M |
| PureTech Health | 480.54M |
| Theravance Biopharma | 478.47M |
| InnovAge Holding | 478.16M |
| Alumis | 469.54M |
| AnaptysBio | 456.43M |
| MeiraGTx Holdings | 456.42M |
| Zevra Therapeutics | 455.83M |